טוען...
Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients
We recount a single-center experience with cardiac immunity-related adverse effects in patients treated with immune checkpoint inhibitors. Of 2,830 patients, 9 patients (0.3%) developed cardiac immunity-related adverse effects (4 cases of cardiomyopathies, 2 of myocarditis, 2 of acute pericarditis,...
שמור ב:
| הוצא לאור ב: | JACC Case Rep |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8298653/ https://ncbi.nlm.nih.gov/pubmed/34317203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2019.11.080 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|